Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02321293
Title A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Lady Davis Institute
Indications

lung non-small cell carcinoma

Therapies

Erlotinib + Gefitinib

Age Groups: adult
Covered Countries CAN


No variant requirements are available.